Visual impairment and blindness in type 2 diabetics: Ife-Ijesa diabetic retinopathy study

International Ophthalmology

Volumn 36, Issue 4, 2016, Pages 477-485

  Onakpoya, O H ^a   Kolawole, B A ^a   Adeoye, A O ^a   Adegbehingbe, B O ^a   Laoye, O ^a  

^a OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

Author keywords

Blindness; Cataract; Diabetic eye diseases; Diabetic retinopathy; Nigeria

Indexed keywords

ADULT; AGED; ARTICLE; BLINDNESS; CATARACT; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; EYE EXAMINATION; FEMALE; GLAUCOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OPHTHALMOSCOPY; OUTCOME ASSESSMENT; PREVALENCE; PROSPECTIVE STUDY; REFRACTION ERROR; VISUAL IMPAIRMENT; CROSS-SECTIONAL STUDY; DIABETES MELLITUS, TYPE 2; MIDDLE AGED; NIGERIA; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; VISUALLY IMPAIRED PERSON; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BLINDNESS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; MIDDLE AGED; NIGERIA; OPHTHALMOSCOPY; PREVALENCE; PROSPECTIVE STUDIES; VISUALLY IMPAIRED PERSONS; YOUNG ADULT;

EID: 84946148105     PISSN: 01655701     EISSN: 15732630     Source Type: Journal    
DOI: 10.1007/s10792-015-0145-8     Document Type: Article

References (46)

1. Winter I, Yorston D (2011) Diabetic retinopathy: everybody’s business. Community Eye Health J 24:1–2
2. Van DS, Beulens JWJ, Van der SYT, Grobbee DE, Nealb B (2010) The global burden of diabetes and its complications; an emerging pandemic. Eur J Prev Cardiol 17:s3–s8
3. Abdull MM, Sivasubramaniam S, Murthy GVS, Gilbert C, Abubakar T, Ezelum C, Rabiu MM, on behalf of Nigeria National Blindness and Visual Impairment Study Group (2009) Causes of blindness and visual impairment in Nigeria: the Nigeria national blindness and visual impairment survey. IVOS 50:4114–4120
4. Hall V, Thomsein RW, Heriksen O, Lohse N (2011) Diabetes in Sub-Saharan Africa 1999–2011: epidemiology and public health implications a systematic review. BMC Public Health 11:564
5. International Diabetes Federation (IDF) Diabetes Atlas, 6th edn, IDF, 2014. www.idf.org. Accessed Sept 2015
6. Pascolini D, Marriotti SP (2011) Global estimates of visual impairment. Br J Ophthalmol 2011
7. Zhang X, Greff EW, Chang YJ et al (2008) Diabetes mellitus and visual impairment: national health and nutrition examination survey 1999–2004. Arch Ophthalmol 26:1421–1427
8. Congdon NG, Friedman DS, Lietman T (2003) Important causes of visual impairment in the world today. JAMA 290:2057–2060
9. Glover SJ, Burgess PI, Cohen DB et al (2012) Prevalence of diabetic retinopathy, cataract and visual impairment in patients with diabetes in sub Saharan Africa. Br J Ophthalmol 96:156–161
10. Jeganathan VS, Wang JJ, Wong TY (2008) Ocular associations of diabetes other than diabetic retinopathy. Diabetes Care 31:1903–1912
11. Farrel IC, Muran J (2014) Comparison of comorbidities in patients with prediabetes to those with diabetes mellitus type 2. Ir Med J 107:72–74
12. Nguyen HT, Luzio SD, Dolben J, West J, Beck L, Coates PA, Owens DR (1996) Dominant risk factors for retinopathy at clinical diagnosis in patients with type II diabetes mellitus. J Diabetes Complicat 10:211–219
13. Kyari F, Tafida A, Sivasubramaniam S, Murthy GV, Peto T, Gilbert CE, Nigeria National Blindness and Visual Impairment Study Group (2014) Prevalence and risk factors for diabetes and diabetic retinopathy: results from the Nigeria national blindness and visual impairment survey. BMC Public Health 14:1299
14. Idemyor V (2010) Diabetes in sub-Saharan Africa: health care perspectives, challenges, and the economic burden of disease. J Natl Med Assoc 102:650–653
15. Flessa S, Zembok A (2014) Costing of diabetes mellitus type II in Cambodia. Health Econ Rev 4:24
16. Bandello F, Casalino G, Loewenstein A, Goldstein M, Pelayes D, Battaglia Parodi M (2014) Pharmacological approach to diabetic macular edema. Ophthalmic Res 51:88–95
17. Pershing S, Enns EA, Matesic B, Owens DK, Goldhaber-Fiebert JD (2014) Cost-effectiveness of treatment of diabetic macular edema. Ann Intern Med 160:18–29
18. Patelli F, Radice P, Giacomotti E (2014) Diabetic macular edema. Dev Ophthalmol 54:164–173
19. Wang JE, Zhang RY, Chen RP et al (2013) Prevalence and risk factors for diabetic retinopathy in a high-risk Chinese population. BMC Public Health 13:633–639
20. Tapp RJ, Shaw JE, Harper CA, De Courten MP, Balkau B, McCarty DJ, Taylor HR, Welborn TA, Zimmet PZ, AusDiab Study Group (2003) The prevalence of and factors associated with diabetic retinopathy in Australian population. Diabetes Care 26:1731–1737
21. Mowatt L (2013) Diabetic retinopathy and its risk factors at the university Hospital in Jamaica. Middle East Afr J Ophthal 20:321–326
22. Li L, Wan XH, Zhao GH (2014) Metaanalysis of the risk of cataract in type 2 diabetes. BMC Ophthalmol 14:94–107
23. Murtha T, Cavellerano J (2007) The management of diabetic eye disease in the setting of cataract surgery. Curr Opin Ophthalmol 18:13–18
24. Patel SV, Holmes JM, Hodge DO, Burke JP (2005) Diabetes and hypertension in isolated sixth nerve palsy; a population based study. Ophthalmology 112:760–763
25. Lin SF, Lin PK, Chang FL, Tsai RK (2009) Transient hyperopia after intense treatment of hyperglycemia in newly diagnosed diabetes. Ophthalmologica 223:68–71
26. www.population.gov.ng/index.php/census. Accessed Sept 2015
27. Kahn Richard (2003) Follow up Report on the diagnosis of diabetes mellitus. The Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes care 26:3160–3167
28. World Health Organisation International statistical classification of diseases and related health problems 10th revision Current version. Version 2003 Chapter VII H54 Blindness and low vision. http://ophthaclassification.altervista.org/international-clinical-diabetic-retinopathy-disease-severity-scale/. Accessed Sept 2015
29. http://ophthaclassification.altervista.org/international-clinical-diabetic-retinopathy-disease-severity-scale/. Accessed Sept 2015
30. Colosia AD, Palencia R, Khan S (2013) Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review. Diabetes Metab Syndr Obes 6:327–338
31. Harris MD (2003) Psychosocial aspects of diabetes with an emphasis on depression. Curr Diabetes Rep 3:49–55
32. Rani PK, Raman R, Gella L, Kulothingan V, Sharma T (2012) Prevalence of visual impairment and associated risk factor in subjects with type 2 diabetes mellitus: Sankara Nethralaya diabetic retinopathy epidemiology and molecular genetic study(SN-DREAMS; Report 16). Middle East Afr J Ophthalmol 19:129–134
33. Al-Till MI, Al-Badour MD, Ajlouni KM (2005) Prevalence of blindness and visual impairment among Jordanian diabetics. Eur J Ophthalmol 15:62–68
34. Pollreisz A, Schmidt-Erfurth U (2010) Diabetic cataract pathogenesis, epidemiology and treatment. J Ophthalmol. doi:10.1155/2010/608751
35. Hashim Z, Zarina S (2012) Osmotic stress induced oxidative damage: possible mechanism of cataract formation in diabetes. J Diabetes Complicat 26:275–276
36. Bonovas S, Peponis V, Filioussi K (2004) Diabetes mellitus as a risk factor for primary open angle glaucoma; a metaanalysis. Diabet Med 21:609–614
37. Zhoun M, Wang W, Huang W, Zhang X (2014) Diabetes mellitus as a risk factor for open angle glaucoma; a systematic review and meta-analysis. PLoS One 9:e102972
38. Kim SJ, Equi R, Bressler NM (2007) Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography. Ophthalmology 114:881–889
39. Krepler K, Biowsky R, Schrey S, Jandrasits K, Wedrich A (2002) Cataract surgery in patients with diabetic retinopathy; visual outcome, progression of diabetic retinopathy and incidence of diabetic macular edema. Graefe’s Arch Clin Exp Ophthalmol 240:735–738
40. Raman R, Rani PK, Rachepalle SR, Uthra S, Kumaramanickavel G, Sharma T (2009) Prevalence of diabetic retinopathy in India. Sankara Nethralaya diabetic retinopathy epidemiology and molecular genetic study report 2. Ophthalmology 116:311–318
41. Owsley C, McGwin G Jr, Lee DJ, Lam BL, Friedman DS, Gower EW, Haller JA, Hark LA, Saaddine J, for the Innovative Network for Sight (INSIGHT) Research Group (2015) Diabetes eye screening in urban settings serving minority populations detection of diabetic retinopathy and other ocular findings using telemedicine. JAMA Ophthalmol 133:174–181
42. Patil S, Gogate P, Vora S et al (2014) Prevalence and causes of blindness, visual impairment and cataract surgical services in Sindhuburg district in the western coastal strip, India. Indian J Ophthalmol 62:240–245
43. Onakpoya OH, Adeoye AO, Kolawole BA (2010) Determinants of dilated eye examination among type 2 diabetics in Southwestern Nigeria. Eur J Int Med 21:176–179
44. Ellis D, Burges PH, Kayange P (2013) Management of diabetic retinopathy. Malawi Med J 25:116–120
45. Naidoo K, Gichuhi S, Basáñez M-G, Flaxman SR, Jonas JB, Keeffe J, Leasher JL, Pesudovs K, Price H, Smith JL, Turner HC, White RA, Wong TY, Resnikoff S, Taylor HR, Bourne RR, Vision Loss Expert Group of the Global Burden of Disease Study (2014) Prevalence and causes of vision loss in sub-Saharan Africa: 1990–2010. Br J Ophthalmol 98:612–618
46. Baris S, Banu B, Aysegul A, Murat I, Mehmet O, Umut S (2005) Effect of glyceamic control on refractive changes in diabetic patients with hyperglycemia. Cornea 24:531–537